Global Biochip Market, By Technology (Microarray v/s Microfluidics), By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others), By End User (Hospitals & Diagnostics Centers, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Others), By Region, Competition Forecast & Opportunities, 2026

July 2021 | 206 pages | ID: G57DE0487429EN
TechSci Research

Abstracts

Global biochip market was valued at USD11694.24 million in 2020 and is expected to reach USD23890.58 million by 2026, registering a CAGR of 12.52% in the next five years. The global biochip market is driven by the growing prevalence of various chronic and infectious diseases especially in the geriatric population who are more susceptible to these diseases on account of low immunity. This has led to the increase in demand for personalized medicine solutions or targeted therapies especially for diagnosis and treatment of diseases like cancer. This in turn is expected to positively influence the market growth over the next few years. Additionally, increasing R&D activities and supportive government policies further propels the market. However, the high cost of biochips can hamper market growth. Moreover, lack of awareness, especially in the developing and underdeveloped countries, further impedes the market growth.

The global biochip market is segmented based on technology, type, application, end user, company, and region. Based on technology, the market can be bifurcated into microarray and microfluidics. The microarray technology dominated the market in 2020 with a share of around 60.22% and is expected to dominate the market during the forecast period also. This can be attributed to the extensive use of biochips in forensic analysis and identification of drug candidates in the drug discovery process. While the microfluidics technology is expected to witness significant growth over the next few years on account of the increasing use of point of care diagnostic devices such as pregnancy kits, cardiac makers, and blood gases, among others. Based on type, the market can be categorized into DNA Chips, Lab-On-a-Chips, Protein Chips and others. The DNA chips segment is expected to dominate the market during the forecast period. This can be ascribed to the widespread adoption of DNA chips. Additionally, growing expenditure related to genomics and next-generation sequencing along with rising demand for detection and diagnosis of genetic disorders is further expected to support the market growth.

Regionally, North America represented a major share of the global market and is anticipated to continue its dominance in the forecast period. This is directly related to a rise in cancer incidence in the region. In 2020, cancers such as, prostate, lung, and colorectal accounted for approximately 43% of all cancers diagnosed in men. In case of women, breast, lung, and colorectal cancers are the most common cancers and they account for an estimated 50% of all new cancer diagnosed in women in the year 2020. Additionally, growing burden of different diseases is further expected to fuel the market growth.

The major players operating in the global biochip market are Abbott Laboratories Ltd., Agilent Technologies, Inc., PerkinElmer Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, BioM?rieux SA, HORIBA, Ltd., QIAGEN N.V., Randox Laboratories Ltd., OriGene Technologies, Inc., Cepheid (Danaher Corporation) and others. Major companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers and acquisitions and new product developments. For instance, In March 2020, Agilent Technologies, Inc. developed three new GenetiSure Cyto microarrays for prenatal and postnatal research.

Years considered for this report:

Historical Year: 2016-2019

• Base Year: 2020
• Estimated Year: 2021
• Forecast Period: 2022-2026

Objective of the Study:

• To analyze the historical growth in the market size of the global biochip market from 2016 to 2020.
• To estimate and forecast the market size of the global biochip market from 2021 to 2026 and growth rate until 2026.
• To classify and forecast the global biochip market based on type, technology, application, end user, company, and regional distribution.
• To identify dominant region or segment in the global biochip market.
• To identify drivers and challenges for the global biochip market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global biochip market.
• To conduct pricing analysis for the global biochip market.
• To identify and analyze the profile of leading players operating in the global biochip market.
• To identify key sustainable strategies adopted by market players in the global biochip market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global biochip market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Biochip manufacturers/ suppliers/ distributors
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to biochips

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global biochip market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Global Biochip Market, By Technology:
• Microarray
• Microfluidics
• Global Biochip Market, By Type:
• DNA Chips
• Lab-On-a-Chips
• Protein Chips
• Others
• Global Biochip Market, By Application:
• Drug Discovery & Development
• Disease Diagnostics
• Genomics
• Proteomics
• Others
• Global Biochip Market, By End User:
• Hospitals & Diagnostics Centers
• Academic & Research Institutes
• Biotechnology & Pharmaceutical Companies
• Others
• Global Biochip Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global biochip market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five)

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. IMPACT OF COVID-19 ON GLOBAL BIOCHIP MARKET

4. EXECUTIVE SUMMARY

5. VOICE OF CUSTOMER

5.1. Brand Awareness
5.2. Major Benefits of Using Biochips
5.3. Preferred Biochips, Based on Technology

6. GLOBAL BIOCHIP MARKET OUTLOOK, 2016-2026F

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Technology (Microarray v/s Microfluidics)
  6.2.2. By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others)
  6.2.3. By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others)
  6.2.4. By End User (Hospitals & Diagnostics Centers, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Others)
  6.2.5. By Region
  6.2.6. By Company (2020)
6.3. Product Market Map

7. NORTH AMERICA BIOCHIP MARKET OUTLOOK, 2016-2026F

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Technology
  7.2.2. By Type
  7.2.3. By Application
  7.2.4. By End User
  7.2.5. By Country
7.3. North America: Country Analysis
  7.3.1. United States Biochip Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Technology
      7.3.1.2.2. By Type
      7.3.1.2.3. By Application
      7.3.1.2.4. By End User
  7.3.2. Canada Biochip Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Technology
      7.3.2.2.2. By Type
      7.3.2.2.3. By Application
      7.3.2.2.4. By End User
  7.3.3. Mexico Biochip Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Technology
      7.3.3.2.2. By Type
      7.3.3.2.3. By Application
      7.3.3.2.4. By End User

8. EUROPE BIOCHIP MARKET OUTLOOK, 2016-2026F

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Technology
  8.2.2. By Type
  8.2.3. By Application
  8.2.4. By End User
  8.2.5. By Country
8.3. Europe: Country Analysis
  8.3.1. United Kingdom Biochip Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Technology
      8.3.1.2.2. By Type
      8.3.1.2.3. By Application
      8.3.1.2.4. By End User
  8.3.2. Germany Biochip Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Technology
      8.3.2.2.2. By Type
      8.3.2.2.3. By Application
      8.3.2.2.4. By End User
  8.3.3. France Biochip Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Technology
      8.3.3.2.2. By Type
      8.3.3.2.3. By Application
      8.3.3.2.4. By End User
  8.3.4. Italy Biochip Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Technology
      8.3.4.2.2. By Type
      8.3.4.2.3. By Application
      8.3.4.2.4. By End User
  8.3.5. Spain Biochip Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Technology
      8.3.5.2.2. By Type
      8.3.5.2.3. By Application
      8.3.5.2.4. By End User

9. ASIA-PACIFIC BIOCHIP MARKET OUTLOOK, 2016-2026F

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Technology
  9.2.2. By Type
  9.2.3. By Application
  9.2.4. By End User
  9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
  9.3.1. China Biochip Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Technology
      9.3.1.2.2. By Type
      9.3.1.2.3. By Application
      9.3.1.2.4. By End User
  9.3.2. Japan Biochip Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Technology
      9.3.2.2.2. By Type
      9.3.2.2.3. By Application
      9.3.2.2.4. By End User
  9.3.3. India Biochip Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Technology
      9.3.3.2.2. By Type
      9.3.3.2.3. By Application
      9.3.3.2.4. By End User
  9.3.4. South Korea Biochip Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Technology
      9.3.4.2.2. By Type
      9.3.4.2.3. By Application
      9.3.4.2.4. By End User
  9.3.5. Australia Biochip Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Technology
      9.3.5.2.2. By Type
      9.3.5.2.3. By Application
      9.3.5.2.4. By End User

10. SOUTH AMERICA BIOCHIP MARKET OUTLOOK, 2016-2026F

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Technology
  10.2.2. By Type
  10.2.3. By Application
  10.2.4. By End User
  10.2.5. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Biochip Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Technology
      10.3.1.2.2. By Type
      10.3.1.2.3. By Application
      10.3.1.2.4. By End User
  10.3.2. Argentina Biochip Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Technology
      10.3.2.2.2. By Type
      10.3.2.2.3. By Application
      10.3.2.2.4. By End User
  10.3.3. Colombia Biochip Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Technology
      10.3.3.2.2. By Type
      10.3.3.2.3. By Application
      10.3.3.2.4. By End User

11. MIDDLE EAST AND AFRICA BIOCHIP MARKET OUTLOOK, 2016-2026F

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Technology
  11.2.2. By Type
  11.2.3. By Application
  11.2.4. By End User
  11.2.5. By Country
11.3. MEA: Country Analysis
  11.3.1. South Africa Biochip Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Technology
      11.3.1.2.2. By Type
      11.3.1.2.3. By Application
      11.3.1.2.4. By End User
  11.3.2. Saudi Arabia Biochip Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Technology
      11.3.2.2.2. By Type
      11.3.2.2.3. By Application
      11.3.2.2.4. By End User
  11.3.3. UAE Biochip Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Technology
      11.3.3.2.2. By Type
      11.3.3.2.3. By Application
      11.3.3.2.4. By End User

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. COMPETITIVE LANDSCAPE

14.1. Competition Outlook
14.2. Company Profiles
  14.2.1. Abbott Laboratories Inc.
  14.2.2. Agilent Technologies, Inc.
  14.2.3. PerkinElmer Inc.
  14.2.4. Fluidigm Corporation
  14.2.5. Illumina, Inc.
  14.2.6. GE Healthcare Inc.
  14.2.7. Bio-Rad Laboratories Inc.
  14.2.8. Thermo Fisher Scientific, Inc.
  14.2.9. F. Hoffmann-La Roche AG
  14.2.10. BioM?rieux SA
  14.2.11. HORIBA, Ltd.
  14.2.12. QIAGEN N.V.
  14.2.13. Randox Laboratories Ltd.
  14.2.14. OriGene Technologies, Inc.
  14.2.15. Cepheid (Danaher Corporation)

15. STRATEGIC RECOMMENDATIONS

16. ABOUT US & DISCLAIMER

List Of Figures

LIST OF FIGURES

Figure 1: Global Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 2: Research & Development Expenditure of Top 5 Countries (USD Billion), As of 2021
Figure 3: Global Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 4: Global Biochip Market Share, By Type, By Value, 2016-2026F
Figure 5: Global Biochip Market Share, By Application, By Value, 2016-2026F
Figure 6: Global Biochip Market Share, By End User, By Value, 2016-2026F
Figure 7: Global Biochip Market Share, By Region, By Value, 2016-2026F
Figure 8: Global Biochip Market Share, By Company, By Value, 2020
Figure 9: Global Biochip Market Map, By Technology, Market Size (USD Million) & Growth Rate (%)
Figure 10: Global Biochip Market Map, By Type, Market Size (USD Million) & Growth Rate (%)
Figure 11: North America Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 12: North America Undiagnosed and Diagnosed Diabetes Cases, 2019
Figure 13: North America Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 14: North America Biochip Market Share, By Type, By Value, 2016-2026F
Figure 15: North America Biochip Market Share, By Application, By Value, 2016-2026F
Figure 16: North America Biochip Market Share, By End User, By Value, 2016-2026F
Figure 17: North America Biochip Market Share, By Country, By Value, 2016-2026F
Figure 18: United States Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 19: New Cancer Cases Reported in the United States in 2020, Both Sexes, All Ages
Figure 20: United States Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 21: United States Biochip Market Share, By Type, By Value, 2016-2026F
Figure 22: United States Biochip Market Share, By Application, By Value, 2016-2026F
Figure 23: United States Biochip Market Share, By End User, By Value, 2016-2026F
Figure 24: Canada Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 25: Canada Forensic Technology Market Size, By Value, 2015-2025F (USD Billion)
Figure 26: Canada Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 27: Canada Biochip Market Share, By Type, By Value, 2016-2026F
Figure 28: Canada Biochip Market Share, By Application, By Value, 2016-2026F
Figure 29: Canada Biochip Market Share, By End User, By Value, 2016-2026F
Figure 30: Mexico Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 31: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 32: Mexico Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 33: Mexico Biochip Market Share, By Type, By Value, 2016-2026F
Figure 34: Mexico Biochip Market Share, By Application, By Value, 2016-2026F
Figure 35: Mexico Biochip Market Share, By End User, By Value, 2016-2026F
Figure 36: Europe Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 37: Leading Cancers in Males in Europe by Incidence and Mortality Common Cancers, 2020
Figure 38: Europe Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 39: Europe Biochip Market Share, By Type, By Value, 2016-2026F
Figure 40: Europe Biochip Market Share, By Application, By Value, 2016-2026F
Figure 41: Europe Biochip Market Share, By End User, By Value, 2016-2026F
Figure 42: Europe Biochip Market Share, By Country, By Value, 2016-2026F
Figure 43: United Kingdom Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 44: Geriatric Population Numbers & Projections in United Kingdom (Millions), 2020
Figure 45: United Kingdom Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 46: United Kingdom Biochip Market Share, By Type, By Value, 2016-2026F
Figure 47: United Kingdom Biochip Market Share, By Application, By Value, 2016-2026F
Figure 48: United Kingdom Biochip Market Share, By End User, By Value, 2016-2026F
Figure 49: Germany Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 50: Germany New Cancer Cases, By Type, 2020
Figure 51: Germany Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 52: Germany Biochip Market Share, By Type, By Value, 2016-2026F
Figure 53: Germany Biochip Market Share, By Application, By Value, 2016-2026F
Figure 54: Germany Biochip Market Share, By End User, By Value, 2016-2026F
Figure 55: France Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 56: France Bioinformatics Market Size, By Value (USD Billion), 2016-2026F
Figure 57: France Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 58: France Biochip Market Share, By Type, By Value, 2016-2026F
Figure 59: France Biochip Market Share, By Application, By Value, 2016-2026F
Figure 60: France Biochip Market Share, By End User, By Value, 2016-2026F
Figure 61: Italy Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 62: Italy Forensic Technology Market Size, By Value, 2015-2025F (USD Billion)
Figure 63: Italy Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 64: Italy Biochip Market Share, By Type, By Value, 2016-2026F
Figure 65: Italy Biochip Market Share, By Application, By Value, 2016-2026F
Figure 66: Italy Biochip Market Share, By End User, By Value, 2016-2026F
Figure 67: Spain Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 68: Number of New Cancer Cases in Spain, By Cancer Site, 2020
Figure 69: Spain Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 70: Spain Biochip Market Share, By Type, By Value, 2016-2026F
Figure 71: Spain Biochip Market Share, By Application, By Value, 2016-2026F
Figure 72: Spain Biochip Market Share, By End User, By Value, 2016-2026F
Figure 73: Asia Pacific Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 74: Number of New Cancer Cases in Asia Pacific (2020)
Figure 75: Asia Pacific Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 76: Asia Pacific Biochip Market Share, By Type, By Value, 2016-2026F
Figure 77: Asia Pacific Biochip Market Share, By Application, By Value, 2016-2026F
Figure 78: Asia Pacific Biochip Market Share, By End User, By Value, 2016-2026F
Figure 79: Asia Pacific Biochip Market Share, By Country, By Value, 2016-2026F
Figure 80: China Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 81: China Bioinformatics Market Size, By Value (USD Billion), 2016-2026F
Figure 82: China Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 83: China Biochip Market Share, By Type, By Value, 2016-2026F
Figure 84: China Biochip Market Share, By Application, By Value, 2016-2026F
Figure 85: China Biochip Market Share, By End User, By Value, 2016-2026F
Figure 86: Japan Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 87: Japan Total Health Expenditure as a share of GDP, 2015- 2019
Figure 88: Japan Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 89: Japan Biochip Market Share, By Type, By Value, 2016-2026F
Figure 90: Japan Biochip Market Share, By Application, By Value, 2016-2026F
Figure 91: Japan Biochip Market Share, By End User, By Value, 2016-2026F
Figure 92: India Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 93: Growing Share of Geriatric Population (Above 60 Years) in India (2015-2019)
Figure 94: India Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 95: India Biochip Market Share, By Type, By Value, 2016-2026F
Figure 96: India Biochip Market Share, By Application, By Value, 2016-2026F
Figure 97: India Biochip Market Share, By End User, By Value, 2016-2026F
Figure 98: South Korea Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 99: New Cancer Cases in South Korea (%), 2019
Figure 100: South Korea Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 101: South Korea Biochip Market Share, By Type, By Value, 2016-2026F
Figure 102: South Korea Biochip Market Share, By Application, By Value, 2016-2026F
Figure 103: South Korea Biochip Market Share, By End User, By Value, 2016-2026F
Figure 104: Australia Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 105: Australia Forensic Technology Market Size, By Value, 2015-2025F (USD Billion)
Figure 106: Australia Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 107: Australia Biochip Market Share, By Type, By Value, 2016-2026F
Figure 108: Australia Biochip Market Share, By Application, By Value, 2016-2026F
Figure 109: Australia Biochip Market Share, By End User, By Value, 2016-2026F
Figure 110: South America Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 111: Central and South America Diagnosed and Undiagnosed Diabetes Cases, 2019
Figure 112: South America Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 113: South America Biochip Market Share, By Type, By Value, 2016-2026F
Figure 114: South America Biochip Market Share, By Application, By Value, 2016-2026F
Figure 115: South America Biochip Market Share, By End User, By Value, 2016-2026F
Figure 116: South America Biochip Market Share, By Country, By Value, 2016-2026F
Figure 117: Brazil Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 118: Brazil Healthcare Spending, By Value (USD Per Capita), 2015-2019
Figure 119: Brazil Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 120: Brazil Biochip Market Share, By Type, By Value, 2016-2026F
Figure 121: Brazil Biochip Market Share, By Application, By Value, 2016-2026F
Figure 122: Brazil Biochip Market Share, By End User, By Value, 2016-2026F
Figure 123: Argentina Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 124: Argentina Bioinformatics Market Size, By Value (USD Billion), 2016-2026F
Figure 125: Argentina Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 126: Argentina Biochip Market Share, By Type, By Value, 2016-2026F
Figure 127: Argentina Biochip Market Share, By Application, By Value, 2016-2026F
Figure 128: Argentina Biochip Market Share, By End User, By Value, 2016-2026F
Figure 129: Colombia Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 130: New Cancer Cases in Colombia (%), 2019
Figure 131: Colombia Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 132: Colombia Biochip Market Share, By Type, By Value, 2016-2026F
Figure 133: Colombia Biochip Market Share, By Application, By Value, 2016-2026F
Figure 134: Colombia Biochip Market Share, By End User, By Value, 2016-2026F
Figure 135: Middle East & Africa Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 136: Middle East & Africa Geriatric Population Base (Age 60 & Above) % of Total Population, 2015-2019
Figure 137: Middle East & Africa Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 138: Middle East & Africa Biochip Market Share, By Type, By Value, 2016-2026F
Figure 139: Middle East & Africa Biochip Market Share, By Application, By Value, 2016-2026F
Figure 140: Middle East & Africa Biochip Market Share, By End User, By Value, 2016-2026F
Figure 141: Middle East & Africa Biochip Market Share, By Country, By Value, 2016-2026F
Figure 142: South Africa Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 143: South Africa New Cancer Cases, By Type, 2020
Figure 144: South Africa Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 145: South Africa Biochip Market Share, By Type, By Value, 2016-2026F
Figure 146: South Africa Biochip Market Share, By Application, By Value, 2016-2026F
Figure 147: South Africa Biochip Market Share, By End User, By Value, 2016-2026F
Figure 148: Saudi Arabia Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 149: Saudi Arabia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 150: Saudi Arabia Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 151: Saudi Arabia Biochip Market Share, By Type, By Value, 2016-2026F
Figure 152: Saudi Arabia Biochip Market Share, By Application, By Value, 2016-2026F
Figure 153: Saudi Arabia Biochip Market Share, By End User, By Value, 2016-2026F
Figure 154: UAE Biochip Market Size, By Value (USD Million), 2016-2026F
Figure 155: % of female population in UAE, 2015-2019
Figure 156: UAE Biochip Market Share, By Technology, By Value, 2016-2026F
Figure 157: UAE Biochip Market Share, By Type, By Value, 2016-2026F
Figure 158: UAE Biochip Market Share, By Application, By Value, 2016-2026F
Figure 159: UAE Biochip Market Share, By End User, By Value, 2016-2026F
Figure 160: Global Population Ages 65 & Above (% of Total Population), 2016-2019
Figure 161: Number of Deaths Caused due to Selected Chronic Diseases in 2019 (in Thousands)